Pharma companies are under pressure to lower prices in the U.S.Novo Nordisk (NVO 1.78%) is struggling with competition in its weight loss treatment business and is looking to make an acquisition to bolster its pipeline of drugs.*Stock prices used were the afternoon prices of Nov. 5, 2025. The video was published on Nov. 7, 2025. ...